Industry NewsImmutep granted Australian patent for Eftilagimod Alpha in combination with a PD-1 pathway inhibitor
Editorial ArticleMeet the winners of the 2022 Scientists’ Choice Awards for Drug Discovery & Development
Expert InsightsHow to improve CMC productivity through digital lab transformation – your questions answered